Impaired growth, delayed ossification, and reduced osteoclastic activity in the growth plate of calcium-supplemented rats with renal failure.
Linear growth is reduced in prepubertal children with adynamic renal osteodystrophy, suggesting that the proliferation and/or differentiation of epiphyseal growth plate chondrocytes is abnormal in this disorder. To examine this issue, in situ hybridization and histochemistry were used to measure selected markers of endochondral bone formation and bone resorption in the proximal tibia of subtotally nephrectomized rats fed a high calcium diet to induce biochemical changes consistent with adynamic osteodystrophy. Blood ionized calcium concentrations were higher and serum PTH levels were lower in nephrectomized, calcium-supplemented rats than in either intact or nephrectomized control animals. Linear growth and tibial length were reduced, but messenger RNA levels for type II collagen, type X collagen, and the PTH/PTHrP receptor did not differ from control values in nephrectomized rats given supplemental calcium. In contrast, both the width of epiphyseal cartilage and the height of the zone of hypertrophic chondrocytes were greater in calcium-supplemented nephrectomized rats. These morphological changes were associated with decreases in histochemical staining for tartrate-resistant acid phosphatase and lower levels of messenger RNA expression for the matrix metalloproteinase MMP-9/gelatinase B immediately adjacent to the epiphyseal growth plate. Diminished chondroclastic/osteoclastic activity alters growth plate morphology and adversely affects linear bone growth in calcium-supplemented, nephrectomized rats.
Sanchez
C P
CP
Department of Pediatrics, School of Medicine, Los Angeles, California 90095, USA.
Kuizon
B D
BD
Abdella
P A
PA
Jüppner
H
H
Salusky
I B
IB
Goodman
W G
WG
D000135:Acid Phosphatase / Q000378:metabolism; D000818:Animals; D015415:Biomarkers; D002118:Calcium / Q000097:blood / Q000494:pharmacology*; D006132:Growth Plate / Q000187:drug effects / Q000254:growth & development* / Q000473:pathology / Q000503:physiopathology*; D007527:Isoenzymes / Q000378:metabolism; D007676:Kidney Failure, Chronic / Q000473:pathology / Q000503:physiopathology*; D008297:Male; D020780:Matrix Metalloproteinase 9 / Q000235:genetics; D009392:Nephrectomy; D010010:Osteoclasts / Q000502:physiology*; D010012:Osteogenesis; D010281:Parathyroid Hormone / Q000097:blood; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D000071681:Tartrate-Resistant Acid Phosphatase; D013977:Tibia / Q000254:growth & development; D013997:Time Factors
D015415:Biomarkers; D007527:Isoenzymes; D010281:Parathyroid Hormone; D012333:RNA, Messenger; D000135:Acid Phosphatase; D000071681:Tartrate-Resistant Acid Phosphatase; D020780:Matrix Metalloproteinase 9; D002118:Calcium